glu-p-2 has been researched along with Uremia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanai, Y; Manabe, S; Wada, O; Yanagisawa, H | 1 |
| Ishikawa, S; Kanai, Y; Kitagawa, Y; Manabe, S; Wada, O; Yanagisawa, H | 1 |
2 other study(ies) available for glu-p-2 and Uremia
| Article | Year |
|---|---|
Carcinogenic glutamic acid pyrolysis product in the dialysate of uremic patients treated by continuous ambulatory peritoneal dialysis.
Topics: Adult; Chromatography, High Pressure Liquid; Dialysis Solutions; Female; Humans; Imidazoles; Male; Middle Aged; Mutagenicity Tests; Mutagens; Peritoneal Dialysis, Continuous Ambulatory; Salmonella typhimurium; Uremia | 1988 |
Accumulation of 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole and 2-aminodipyrido[1,2-a:3',2'-d]imidazole, carcinogenic glutamic acid pyrolysis products, in plasma of patients with uremia.
Topics: Adult; Carcinogens; Chromatography, High Pressure Liquid; Female; Humans; Imidazoles; Male; Middle Aged; Reference Values; Uremia | 1987 |